CHINA PEDIATRIC PHARMACEUTICALS, INC.: 10-Q filed 2013-08-19
What CHINA PEDIATRIC PHARMACEUTICALS, INC. reported in its quarterly report filed 2013-08-19 (fiscal Q2 2013): 32 published measures, 87 facts as tagged in accession 0001017386-13-000213.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2013-08-19
- Fiscal period
- fiscal Q2 2013
- Accession
- 0001017386-13-000213 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All CHINA PEDIATRIC PHARMACEUTICALS, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 6,420,901 | USD | |
| At 2012-12-31 | 12,119,512 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 5,876,356 | USD | |
| At 2012-12-31 | 11,619,464 | USD | |
| At 2011-12-31 | 20,597,650 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,475,983 | USD | |
| At 2012-12-31 | 1,102,349 | USD | |
| At 2012-06-30 | 2,513,263 | USD | |
| At 2011-12-31 | 2,186,650 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -1,179,214 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -5,923,180 | USD | 181 |
| 2012-01-01 to 2012-12-31 | -9,152,318 | USD | 366 |
| 2012-04-01 to 2012-06-30 | -451,126 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -2,237,552 | USD | 182 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 408,502 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 332,938 | USD | 182 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -61,220 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -21,552 | USD | 182 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 761,567 | USD | |
| At 2012-12-31 | 791,405 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-06-30 | 15,625 | USD | 182 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -1,179,206 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -5,923,172 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -451,049 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -2,237,417 | USD | 182 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 4,323,325 | USD | |
| At 2012-12-31 | 9,881,061 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 544,545 | USD | |
| At 2012-12-31 | 500,048 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 13,669 | USD | |
| At 2012-12-31 | 84,373 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,504,610 | USD | |
| At 2012-12-31 | 4,673,315 | USD |
Net inventory
Inventory carrying amount after applicable valuation and LIFO reserves. It does not establish realizable selling proceeds or inventory turnover without other inputs.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 140,141 | USD | |
| At 2012-12-31 | 472,274 | USD |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 312,952 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 691,989 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 2,379,665 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 4,081,741 | USD | 182 |
Cost of revenue
Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 123,949 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 245,180 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 816,070 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 1,844,951 | USD | 182 |
Selling, general and administrative expense
Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 452,674 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 878,973 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 1,272,601 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 2,142,586 | USD | 182 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 44,556,104 | shares | |
| At 2012-12-31 | 44,556,104 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 14,102,507 | USD | |
| At 2012-12-31 | 14,102,507 | USD |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 3,376,837 | USD | |
| At 2012-12-31 | 3,196,765 | USD |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,768,487 | USD | |
| At 2012-12-31 | 1,732,633 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,006,920 | USD | |
| At 2012-12-31 | 941,228 | USD |
Net intangible assets excluding goodwill
Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2013-06-30 | 1,336,009 | USD | |
| At 2012-12-31 | 1,447,046 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -1,179,214 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -5,923,180 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -451,126 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -2,237,552 | USD | 182 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -1,057,515 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -5,743,108 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -439,994 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -2,093,367 | USD | 182 |
Depreciation expense
Depreciation recognized for the period under this concept. It is a noncash allocation of asset cost and may exclude amortization and depletion reported elsewhere.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 22,904 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 45,749 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 23,275 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 46,622 | USD | 182 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 185,308 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 184,625 | USD | 182 |
Amortization of intangible assets
Amortization recognized on finite-lived intangible assets. It follows acquisition accounting and does not indicate the intangibles are losing usefulness at that rate.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | 70,198 | USD | 91 |
| 2013-01-01 to 2013-06-30 | 139,559 | USD | 181 |
| 2012-04-01 to 2012-06-30 | 68,944 | USD | 91 |
| 2012-01-01 to 2012-06-30 | 138,003 | USD | 182 |
Nonoperating income or expense
Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-04-01 to 2013-06-30 | -8 | USD | 91 |
| 2013-01-01 to 2013-06-30 | -8 | USD | 181 |
| 2012-04-01 to 2012-06-30 | -77 | USD | 91 |
| 2012-01-01 to 2012-06-30 | -135 | USD | 182 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -247,116 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -1,033,196 | USD | 182 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | 338,456 | USD | 181 |
| 2012-01-01 to 2012-06-30 | -395,781 | USD | 182 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2013-01-01 to 2013-06-30 | -71,720 | USD | 181 |
| 2012-01-01 to 2012-06-30 | 111,545 | USD | 182 |
Inspect the source
- Entity
- CHINA PEDIATRIC PHARMACEUTICALS, INC. / CIK 0001354071
- Captured
- SEC response SHA-256
9fa973e7cfeb332db52412b0c379de3e69dd9dc277445b38b119cd4940a59804
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001354071.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))